Raffaele Campisi

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2023

Asthma is one of the most common chronic respiratory diseases, affecting over 300 million people worldwide [...]

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (7)

Girolamo Pelaia

Professor of Respiratory Medicine

Magna Graecia University

ITALY

View details

Giulia Scioscia

University of Foggia

ITALY

View details

Andrea Cortegiani

Associate Professsor

Università degli Studi di Palermo

ITALY

View details

Nicola Scichilone

University of Palermo

ITALY

View details

Luisa RICCIARDI

University of Messina

ITALY

View details

Alessandro Vatrella

Associate Professor

Università degli Studi della Campania Luigi Vanvitelli Scuola di Medicina e Chirurgia

ITALY

View details

Claudia Crimi

University of Catania

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Raffaele Campisi

Research Interests

Explore related searches

Contact this professor

Articles (11)

Benralizumab Effectiveness in Severe Eosinophilic Asthma with Co-Presence of Bronchiectasis: A Real-World Multicentre Observational Study

Personalized Medicine in Asthma: Current Approach and Future Perspectives

Switching Biological Therapies in Severe Asthma

Long-Term Domiciliary High-Flow Nasal Therapy in Patients with Bronchiectasis: A Preliminary Retrospective Observational Case-Control Study

Impact of asthma on bronchiectasis severity and risk of exacerbations

Sleep quality and mental health during the COVID-19 pandemic in patients with severe obstructive sleep apnea

Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study

Switch from Omalizumab to Benralizumab in Allergic Patients with Severe Eosinophilic Asthma: A Real-Life Experience from Southern Italy

Switch from Omalizumab to Benralizumab in Allergic Patients with Severe Eosinophilic Asthma: A Real-Life Experience from Southern Italy

Type 2-High Severe Asthma with and without Bronchiectasis: A Prospective Observational Multicentre Study

Better outcomes for everybody evaluates the effectiveness and cost-effectiveness of a pharmacist-led intervention, delivered by community pharmacists in collaboration with physicians, in improving disease control, compared with usual care, in asthma and COPD patients during and after COVID-19

Collaborators (7)

Girolamo Pelaia

Giulia Scioscia

Andrea Cortegiani

Nicola Scichilone

Luisa RICCIARDI

Alessandro Vatrella

Claudia Crimi

Make your next move.